Ilsung Is Dividends and Buybacks
Dividend criteria checks 2/6
Ilsung Is is a dividend paying company with a current yield of 9.2%. Next payment date is on 11th April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
9.4%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 9.4% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | 11 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | ₩1.500k |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Feb 20
Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?
Jan 16Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like
Dec 18
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Nov 21Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A003120 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: A003120's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Ilsung Is Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A003120) | 9.4% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A003120) (up to 3 years) | n/a |
Notable Dividend: A003120's dividend (9.2%) is higher than the bottom 25% of dividend payers in the KR market (1.22%).
High Dividend: A003120's dividend (9.2%) is in the top 25% of dividend payers in the KR market (3.95%)
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A003120's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A003120 is paying a dividend but the company has no free cash flows.